 | • レポートコード：QYR9ST02369 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の子宮頸が診断検査市場について調査・分析し、以下の構成でお届け致します。子宮頸が診断検査の種類別には、Pap試験、HPV試験、コルポスコピー、子宮頸部生検に、用途別には、病院、がん緩和ケア診療所、診断センター、薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別子宮頸が診断検査売上データ ・地域別子宮頸が診断検査市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別子宮頸が診断検査市場規模：Pap試験、HPV試験、コルポスコピー、子宮頸部生検 ・用途別子宮頸が診断検査市場規模：病院、がん緩和ケア診療所、診断センター、薬局 ・主要メーカーの企業情報：F. Hoffmann-La Roche、GlaxoSmithKline、Merck、Advaxis Immunotherapies、Bionor Pharma、Dendreon Corporation、Inovio Pharmaceuticals、ISA Pharmaceuticals、Otsuka Pharmaceuticals、Profectus Biosciences、Virometix、Hologic ・子宮頸が診断検査の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract. North America accounted for the largest share of the global market, followed by Europe.
Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region.
The global Cervical Cancer Diagnostic Testing market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cervical Cancer Diagnostic Testing market based on company, product type, end user and key regions.
This report studies the global market size of Cervical Cancer Diagnostic Testing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cervical Cancer Diagnostic Testing in these regions.
This research report categorizes the global Cervical Cancer Diagnostic Testing market by top players/brands, region, type and end user. This report also studies the global Cervical Cancer Diagnostic Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Profectus Biosciences
Virometix
Hologic
Market size by Product
Pap Testing
HPV Testing
Colposcopy
Cervical Biopsies
Market size by End User
Hospitals
Cancer Palliative care clinics
Diagnostic centers
Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cervical Cancer Diagnostic Testing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cervical Cancer Diagnostic Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cervical Cancer Diagnostic Testing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cervical Cancer Diagnostic Testing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cervical Cancer Diagnostic Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cervical Cancer Diagnostic Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Cervical Cancer Diagnostic Testing Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by Product
1.4.2 Pap Testing
1.4.3 HPV Testing
1.4.4 Colposcopy
1.4.5 Cervical Biopsies
1.5 Market by End User
1.5.1 Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Cancer Palliative care clinics
1.5.4 Diagnostic centers
1.5.5 Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cervical Cancer Diagnostic Testing Market Size
2.1.1 Global Cervical Cancer Diagnostic Testing Revenue 2014-2025
2.1.2 Global Cervical Cancer Diagnostic Testing Sales 2014-2025
2.2 Cervical Cancer Diagnostic Testing Growth Rate by Regions
2.2.1 Global Cervical Cancer Diagnostic Testing Sales by Regions
2.2.2 Global Cervical Cancer Diagnostic Testing Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cervical Cancer Diagnostic Testing Sales by Manufacturers
3.1.1 Cervical Cancer Diagnostic Testing Sales by Manufacturers
3.1.2 Cervical Cancer Diagnostic Testing Sales Market Share by Manufacturers
3.1.3 Global Cervical Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.2 Cervical Cancer Diagnostic Testing Revenue by Manufacturers
3.2.1 Cervical Cancer Diagnostic Testing Revenue by Manufacturers (2014-2019)
3.2.2 Cervical Cancer Diagnostic Testing Revenue Share by Manufacturers (2014-2019)
3.3 Cervical Cancer Diagnostic Testing Price by Manufacturers
3.4 Cervical Cancer Diagnostic Testing Manufacturing Base Distribution, Product Types
3.4.1 Cervical Cancer Diagnostic Testing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cervical Cancer Diagnostic Testing Product Type
3.4.3 Date of International Manufacturers Enter into Cervical Cancer Diagnostic Testing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cervical Cancer Diagnostic Testing Sales by Product
4.2 Global Cervical Cancer Diagnostic Testing Revenue by Product
4.3 Cervical Cancer Diagnostic Testing Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cervical Cancer Diagnostic Testing Breakdown Data by End User
6 North America
6.1 North America Cervical Cancer Diagnostic Testing by Countries
6.1.1 North America Cervical Cancer Diagnostic Testing Sales by Countries
6.1.2 North America Cervical Cancer Diagnostic Testing Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cervical Cancer Diagnostic Testing by Product
6.3 North America Cervical Cancer Diagnostic Testing by End User
7 Europe
7.1 Europe Cervical Cancer Diagnostic Testing by Countries
7.1.1 Europe Cervical Cancer Diagnostic Testing Sales by Countries
7.1.2 Europe Cervical Cancer Diagnostic Testing Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cervical Cancer Diagnostic Testing by Product
7.3 Europe Cervical Cancer Diagnostic Testing by End User
8 Asia Pacific
8.1 Asia Pacific Cervical Cancer Diagnostic Testing by Countries
8.1.1 Asia Pacific Cervical Cancer Diagnostic Testing Sales by Countries
8.1.2 Asia Pacific Cervical Cancer Diagnostic Testing Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cervical Cancer Diagnostic Testing by Product
8.3 Asia Pacific Cervical Cancer Diagnostic Testing by End User
9 Central & South America
9.1 Central & South America Cervical Cancer Diagnostic Testing by Countries
9.1.1 Central & South America Cervical Cancer Diagnostic Testing Sales by Countries
9.1.2 Central & South America Cervical Cancer Diagnostic Testing Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cervical Cancer Diagnostic Testing by Product
9.3 Central & South America Cervical Cancer Diagnostic Testing by End User
10 Middle East and Africa
10.1 Middle East and Africa Cervical Cancer Diagnostic Testing by Countries
10.1.1 Middle East and Africa Cervical Cancer Diagnostic Testing Sales by Countries
10.1.2 Middle East and Africa Cervical Cancer Diagnostic Testing Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cervical Cancer Diagnostic Testing by Product
10.3 Middle East and Africa Cervical Cancer Diagnostic Testing by End User
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Products Offered
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Cervical Cancer Diagnostic Testing Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Cervical Cancer Diagnostic Testing Products Offered
11.3.5 Merck Recent Development
11.4 Advaxis Immunotherapies
11.4.1 Advaxis Immunotherapies Company Details
11.4.2 Company Business Overview
11.4.3 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Products Offered
11.4.5 Advaxis Immunotherapies Recent Development
11.5 Bionor Pharma
11.5.1 Bionor Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bionor Pharma Cervical Cancer Diagnostic Testing Products Offered
11.5.5 Bionor Pharma Recent Development
11.6 Dendreon Corporation
11.6.1 Dendreon Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Dendreon Corporation Cervical Cancer Diagnostic Testing Products Offered
11.6.5 Dendreon Corporation Recent Development
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
11.7.5 Inovio Pharmaceuticals Recent Development
11.8 ISA Pharmaceuticals
11.8.1 ISA Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.8.4 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
11.8.5 ISA Pharmaceuticals Recent Development
11.9 Otsuka Pharmaceuticals
11.9.1 Otsuka Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
11.9.5 Otsuka Pharmaceuticals Recent Development
11.10 Profectus Biosciences
11.10.1 Profectus Biosciences Company Details
11.10.2 Company Business Overview
11.10.3 Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Profectus Biosciences Cervical Cancer Diagnostic Testing Products Offered
11.10.5 Profectus Biosciences Recent Development
11.11 Virometix
11.12 Hologic
12 Future Forecast
12.1 Cervical Cancer Diagnostic Testing Market Forecast by Regions
12.1.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Regions 2019-2025
12.1.2 Global Cervical Cancer Diagnostic Testing Revenue Forecast by Regions 2019-2025
12.2 Cervical Cancer Diagnostic Testing Market Forecast by Product
12.2.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Product 2019-2025
12.2.2 Global Cervical Cancer Diagnostic Testing Revenue Forecast by Product 2019-2025
12.3 Cervical Cancer Diagnostic Testing Market Forecast by End User
12.4 North America Cervical Cancer Diagnostic Testing Forecast
12.5 Europe Cervical Cancer Diagnostic Testing Forecast
12.6 Asia Pacific Cervical Cancer Diagnostic Testing Forecast
12.7 Central & South America Cervical Cancer Diagnostic Testing Forecast
12.8 Middle East and Africa Cervical Cancer Diagnostic Testing Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cervical Cancer Diagnostic Testing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Cervical Cancer Diagnostic Testing Product Picture
Table Cervical Cancer Diagnostic Testing Market Segments
Table Key Manufacturers Cervical Cancer Diagnostic Testing Covered
Table Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cervical Cancer Diagnostic Testing Sales Market Share by Product 2014-2025
Figure Pap Testing Product Picture
Table Major Manufacturers of Pap Testing
Figure HPV Testing Product Picture
Table Major Manufacturers of HPV Testing
Figure Colposcopy Product Picture
Table Major Manufacturers of Colposcopy
Figure Cervical Biopsies Product Picture
Table Major Manufacturers of Cervical Biopsies
Table Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Cancer Palliative care clinics
Figure Diagnostic centers
Figure Pharmacies
Figure Cervical Cancer Diagnostic Testing Report Years Considered
Figure Global Cervical Cancer Diagnostic Testing Market Size 2014-2025 (Million US$)
Figure Global Cervical Cancer Diagnostic Testing Sales 2014-2025 (K Units)
Table Global Cervical Cancer Diagnostic Testing Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cervical Cancer Diagnostic Testing Sales by Regions 2014-2019 (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Market Share by Regions 2014-2019
Figure Global Cervical Cancer Diagnostic Testing Sales Market Share by Regions 2014-2019
Figure 2018 Global Cervical Cancer Diagnostic Testing Sales Market Share by Regions
Table Global Cervical Cancer Diagnostic Testing Revenue by Regions 2014-2019 (Million US$)
Table Global Cervical Cancer Diagnostic Testing Revenue Market Share by Regions 2014-2019
Figure Global Cervical Cancer Diagnostic Testing Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cervical Cancer Diagnostic Testing Revenue Market Share by Regions
Table Global Cervical Cancer Diagnostic Testing Sales by Manufacturers (2014-2019) (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Share by Manufacturers (2014-2019)
Figure Global Cervical Cancer Diagnostic Testing Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cervical Cancer Diagnostic Testing Revenue by Manufacturers (2014-2019) (Million USD)
Table Cervical Cancer Diagnostic Testing Revenue Share by Manufacturers (2014-2019)
Figure Cervical Cancer Diagnostic Testing Value Share by Manufacturers in 2018
Table Key Manufacturers Cervical Cancer Diagnostic Testing Price (2014-2019) (USD/Unit)
Table Cervical Cancer Diagnostic Testing Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cervical Cancer Diagnostic Testing Product Type
Table Date of International Manufacturers Enter into Cervical Cancer Diagnostic Testing Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Share by Product (2014-2019)
Figure Global Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure Global Cervical Cancer Diagnostic Testing Sales Market Share by Product in 2018
Table Global Cervical Cancer Diagnostic Testing Revenue by Product (2014-2019) (Million US$)
Table Global Cervical Cancer Diagnostic Testing Revenue Share by Product (2014-2019)
Figure Global Cervical Cancer Diagnostic Testing Revenue Market Share by Product (2014-2019)
Figure Global Cervical Cancer Diagnostic Testing Revenue Market Share by Product in 2018
Table Cervical Cancer Diagnostic Testing Price by Product 2014-2019 (USD/Unit)
Table Global Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Share by End User (2014-2019)
Figure Global Sales Cervical Cancer Diagnostic Testing Market Share by End User (2014-2019)
Figure Global Sales Cervical Cancer Diagnostic Testing Market Share by End User in 2018
Figure North America Cervical Cancer Diagnostic Testing Sales Growth Rate 2014-2019 (K Units)
Figure North America Cervical Cancer Diagnostic Testing Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cervical Cancer Diagnostic Testing Sales by Countries (2014-2019) (K Units)
Table North America Cervical Cancer Diagnostic Testing Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cervical Cancer Diagnostic Testing Sales Market Share by Countries
Table North America Cervical Cancer Diagnostic Testing Revenue by Countries (2014-2019) (Million US$)
Table North America Cervical Cancer Diagnostic Testing Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cervical Cancer Diagnostic Testing Revenue Market Share by Countries
Figure United States Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure United States Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table North America Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure 2018 North America Cervical Cancer Diagnostic Testing Market Share by Product
Table North America Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table North America Cervical Cancer Diagnostic Testing Sales Market Share by End User (2014-2019)
Figure 2018 North America Cervical Cancer Diagnostic Testing Market Share by End User
Figure Europe Cervical Cancer Diagnostic Testing Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cervical Cancer Diagnostic Testing Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cervical Cancer Diagnostic Testing Sales by Countries (2014-2019) (K Units)
Table Europe Cervical Cancer Diagnostic Testing Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cervical Cancer Diagnostic Testing Sales Market Share by Countries
Table Europe Cervical Cancer Diagnostic Testing Revenue by Countries (2014-2019) (Million US$)
Table Europe Cervical Cancer Diagnostic Testing Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cervical Cancer Diagnostic Testing Revenue Market Share by Countries
Figure Germany Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure France Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure UK Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table Europe Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cervical Cancer Diagnostic Testing Market Share by Product
Table Europe Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table Europe Cervical Cancer Diagnostic Testing Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cervical Cancer Diagnostic Testing Market Share by End User
Figure Asia Pacific Cervical Cancer Diagnostic Testing Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cervical Cancer Diagnostic Testing Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cervical Cancer Diagnostic Testing Sales Market Share by Countries
Table Asia Pacific Cervical Cancer Diagnostic Testing Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cervical Cancer Diagnostic Testing Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cervical Cancer Diagnostic Testing Revenue Market Share by Countries
Figure China Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure China Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure India Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cervical Cancer Diagnostic Testing Market Share by Product
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cervical Cancer Diagnostic Testing Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cervical Cancer Diagnostic Testing Market Share by End User
Figure Central & South America Cervical Cancer Diagnostic Testing Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cervical Cancer Diagnostic Testing Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cervical Cancer Diagnostic Testing Sales by Countries (2014-2019) (K Units)
Table Central & South America Cervical Cancer Diagnostic Testing Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cervical Cancer Diagnostic Testing Sales Market Share by Countries
Table Central & South America Cervical Cancer Diagnostic Testing Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cervical Cancer Diagnostic Testing Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cervical Cancer Diagnostic Testing Revenue Market Share by Countries
Figure Brazil Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table Central & South America Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cervical Cancer Diagnostic Testing Market Share by Product
Table Central & South America Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table Central & South America Cervical Cancer Diagnostic Testing Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cervical Cancer Diagnostic Testing Market Share by End User
Figure Middle East and Africa Cervical Cancer Diagnostic Testing Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cervical Cancer Diagnostic Testing Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cervical Cancer Diagnostic Testing Sales Market Share by Countries
Table Middle East and Africa Cervical Cancer Diagnostic Testing Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cervical Cancer Diagnostic Testing Revenue Market Share by Countries
Figure GCC Countries Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cervical Cancer Diagnostic Testing Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cervical Cancer Diagnostic Testing Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cervical Cancer Diagnostic Testing Market Share by Product
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cervical Cancer Diagnostic Testing Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cervical Cancer Diagnostic Testing Market Share by End User
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Advaxis Immunotherapies Company Details
Table Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Advaxis Immunotherapies Recent Development
Table Bionor Pharma Company Details
Table Bionor Pharma Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bionor Pharma Recent Development
Table Dendreon Corporation Company Details
Table Dendreon Corporation Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dendreon Corporation Recent Development
Table Inovio Pharmaceuticals Company Details
Table Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Inovio Pharmaceuticals Recent Development
Table ISA Pharmaceuticals Company Details
Table ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ISA Pharmaceuticals Recent Development
Table Otsuka Pharmaceuticals Company Details
Table Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Pharmaceuticals Recent Development
Table Profectus Biosciences Company Details
Table Profectus Biosciences Cervical Cancer Diagnostic Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Profectus Biosciences Recent Development
Table Virometix Company Details
Table Hologic Company Details
Table Global Cervical Cancer Diagnostic Testing Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Market Share Forecast by Regions 2019-2025
Table Global Cervical Cancer Diagnostic Testing Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cervical Cancer Diagnostic Testing Revenue Market Share Forecast by Regions 2019-2025
Table Global Cervical Cancer Diagnostic Testing Sales Forecast by Product 2019-2025 (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Market Share Forecast by Product 2019-2025
Table Global Cervical Cancer Diagnostic Testing Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cervical Cancer Diagnostic Testing Revenue Market Share Forecast by Product 2019-2025
Table Global Cervical Cancer Diagnostic Testing Sales Forecast by End User 2019-2025 (K Units)
Table Global Cervical Cancer Diagnostic Testing Sales Market Share Forecast by End User 2019-2025
Figure North America Cervical Cancer Diagnostic Testing Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cervical Cancer Diagnostic Testing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cervical Cancer Diagnostic Testing Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cervical Cancer Diagnostic Testing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cervical Cancer Diagnostic Testing Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cervical Cancer Diagnostic Testing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cervical Cancer Diagnostic Testing Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cervical Cancer Diagnostic Testing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cervical Cancer Diagnostic Testing Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cervical Cancer Diagnostic Testing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cervical Cancer Diagnostic Testing Value Chain
Table Cervical Cancer Diagnostic Testing Customers List
Table Cervical Cancer Diagnostic Testing Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
子宮頸が診断検査の世界市場：市場規模・現状・予測 Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body.In 2018, the global Cervical Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the en…- 世界の子宮頸がん診断市場：動向・競争分析 Cervical cancer is a cancer arising from the cervix.High prevalence of cervical cancer in U.S. drives the growth of cervical cancer diagnostic market. The Cervical Cancer Diagnostic market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during …
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 子宮頸がん検査の世界市場：市場規模・現状・予測 Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …